WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients
NCT02182570
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Dermatitis, Atopic
Interventions
DRUG:
WAL 801 CL dry syrup
Sponsor
Boehringer Ingelheim